Examining the Hepatitis B Vaccine Supply Chain: A Case Study in Iran
We focus on Hepatitis B virus as one of the highly contagious infectious diseases and study the Hepatitis B vaccine supply chain. We coordinate interactions between vaccine manufacturers and their innovative upstream suppliers when they cooperate via R&D contracts to bring a new product into the market. We formulate different game theory models to examine how competition and cooperation along with governmental support can foster innovation. We also solve a real case study of the Hepatitis B vaccine market in Iran.
1st Supervisor: Assoc. Prof. Guven Demirel2nd Supervisor: Prof. Brigitte Granville
Milad is a PhD student in Department of Business Analytics and Applied Economics, School of Business and Management.
Prior to joining Queen Mary University of London in September 2022, He received an offer of a place from The University of Auckland, in New Zealand, for doing a PhD in Operations & Supply Chain Management under the supervision of Prof. Tava Lennon Olsen. However, COVID-19 pandemic and New Zealand’s border restrictions deprived him of in-person learning and after one year of online study, he suspended his PhD education.
He obtained BSc and MSc degrees in Industrial Engineering from IAUN in Iran, with a cumulative GPA of 17.14 and 19.57 (out of 20), respectively. His MSc thesis entitled “A blood supply chain mathematical model regarding expiration date and back up facilities: A real case in Esfahan Blood Transfusion Organization” was fulfilled under the supervision of Prof. Reza Tavakkoli-Moghaddam, and Asst. Prof. Omid Boyer.
Link to Google Scholar page: https://scholar.google.com/citations?user=UdjAma4AAAAJ&hl=en&oi=sra